For citations:

Artamonova E.V. Targeted therapy for advanced non-small cell lung cancer with ALK translocation: brigatinib expands our capabilities and ensures success in fight against disease progression. Medical alphabet. 2021;(10):53-60. (In Russ.) https://doi.org/10.33667/2078-5631-2021-10-53-60